Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexi Vasbinder

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Current Cardiology Reports|July 12, 2023
Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related MyocarditisAlexi Vasbinder, Anis Ismail, Joe-Elie Salem, et al.
Cardiology Clinics|November 17, 2024
Cardiovascular Risk Assessment and Prevention in Cardio-Oncology: Beyond Traditional Risk FactorsOmar M Makram, Priyanshu Nain, Alexi Vasbinder, et al.
JACC. Cardiooncology|October 19, 2020
Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac AmyloidosisRichard K Cheng, Wayne C Levy, Alexi Vasbinder, et al.
Journal of the American Heart Association|November 3, 2021
Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac AmyloidosisRichard K Cheng, Alexi Vasbinder, Wayne C Levy, et al.
Cancer Immunology, Immunotherapy : CII|October 5, 2024
Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 eraAllison L Gradone, Vincent T Ma, Alexi Vasbinder, et al.
Circulation|March 11, 2024
Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart AssociationSalim S Hayek, Vlad G Zaha, Carmel Bogle, et al.
Current Cardiology Reports|September 9, 2025
Evolving Cardioprotective Strategies in Cardio-Oncology: A Narrative ReviewElena Wadden, Sanjay Chandrasekhar, Timothy Jordan, et al.
JMIR Research Protocols|July 14, 2025
A Personalized, Texting-Based Conversational Agent to Address Sleep Disturbance in Individuals Who Have Survived Breast Cancer: Protocol for a Pilot Waitlist Randomized Controlled TrialChi-Shan Tsai, Warren Szewczyk, Michelle Drerup, et al.
Cancer|March 12, 2025
The relationship between cardiometabolic abnormalities and mortality in the Women's Health Initiative: A comparison of associations among women with cancer to women without cancerSreejata Raychaudhuri, Eric McLaughlin, Michael L Pennell, et al.
Transplantation Direct|June 2, 2022
Retrospective Evaluation of Rabbit Antithymocyte Globulin Induction in Heart Transplant PatientsGrace Pui-Yun Lee, Richard K Cheng, Alexi Vasbinder, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Current Cardiology Reports|July 12, 2023
Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related MyocarditisAlexi Vasbinder, Anis Ismail, Joe-Elie Salem, et al.
Cardiology Clinics|November 17, 2024
Cardiovascular Risk Assessment and Prevention in Cardio-Oncology: Beyond Traditional Risk FactorsOmar M Makram, Priyanshu Nain, Alexi Vasbinder, et al.
JACC. Cardiooncology|October 19, 2020
Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac AmyloidosisRichard K Cheng, Wayne C Levy, Alexi Vasbinder, et al.
Journal of the American Heart Association|November 3, 2021
Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac AmyloidosisRichard K Cheng, Alexi Vasbinder, Wayne C Levy, et al.
Cancer Immunology, Immunotherapy : CII|October 5, 2024
Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 eraAllison L Gradone, Vincent T Ma, Alexi Vasbinder, et al.
Circulation|March 11, 2024
Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart AssociationSalim S Hayek, Vlad G Zaha, Carmel Bogle, et al.
Current Cardiology Reports|September 9, 2025
Evolving Cardioprotective Strategies in Cardio-Oncology: A Narrative ReviewElena Wadden, Sanjay Chandrasekhar, Timothy Jordan, et al.
JMIR Research Protocols|July 14, 2025
A Personalized, Texting-Based Conversational Agent to Address Sleep Disturbance in Individuals Who Have Survived Breast Cancer: Protocol for a Pilot Waitlist Randomized Controlled TrialChi-Shan Tsai, Warren Szewczyk, Michelle Drerup, et al.
Cancer|March 12, 2025
The relationship between cardiometabolic abnormalities and mortality in the Women's Health Initiative: A comparison of associations among women with cancer to women without cancerSreejata Raychaudhuri, Eric McLaughlin, Michael L Pennell, et al.
Transplantation Direct|June 2, 2022
Retrospective Evaluation of Rabbit Antithymocyte Globulin Induction in Heart Transplant PatientsGrace Pui-Yun Lee, Richard K Cheng, Alexi Vasbinder, et al.
Pageof 5